Niclosamide
CAS No. 50-65-7
Niclosamide ( NSC 178296 )
产品货号. M14728 CAS No. 50-65-7
氯硝柳胺 (BAY2353) 通过抑制 DNA 复制来治疗大多数绦虫感染。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 500MG | ¥288 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥143 | 有现货 |
|
生物学信息
-
产品名称Niclosamide
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述氯硝柳胺 (BAY2353) 通过抑制 DNA 复制来治疗大多数绦虫感染。
-
产品描述Niclosamide(BAY2353) is used for the treatment of most tapeworm infections by inhibiting DNA replication.
-
体外实验Cell Viability Assay Cell Line:BD140A, SW-13 and NCI-H295R cells Concentration:0.6 nM-46 μM Incubation Time:Result:Inhibited cellular proliferation in adrenocortical carcinoma cell lines with the IC50 of 0.12 μM, 0.15 μM, and 0.53 μM in BD140A, SW-13, and NCI-H295R, respectively.Cell Viability Assay Cell Line:Hela cells Concentration:0.05-5 μM Incubation Time:24 hours Result:Inhibited STAT3-mediated luciferase reporter activity with an IC50 of 0.25 μM.Cell Viability Assay Cell Line:Vero E6 cells Concentration:10 μM Incubation Time:2 days Result:Inhibited the synthesis of viral antigens of SARS-CoV in Vero E6 cells.
-
体内实验Animal Model:Nu+/Nu+ mice injected with NCI-H295R cells Dosage:100 mg/kg, 200 mg/kg Administration:Oral gavage; 100 mg/kg, 200 mg/kg; once a week; 8 weeks Result:Showed a 60%-80% inhibition in tumor growth, as compared to the control group.
-
同义词NSC 178296
-
通路JAK/STAT Signaling
-
靶点STAT
-
受体STAT3
-
研究领域Infection
-
适应症——
化学信息
-
CAS Number50-65-7
-
分子量327.12
-
分子式C13H8Cl2N2O4
-
纯度>98% (HPLC)
-
溶解度Ethanol: <1 mg/mL (<1 mM); Water: <1 mg/mL (<1 mM); DMSO: <1 mg/mL (<1 mM)
-
SMILESO=C(NC1=CC=C([N+]([O-])=O)C=C1Cl)C2=CC(Cl)=CC=C2O
-
化学全称5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Ren X, et al. ACS Med Chem Lett, 2010, 1(9), 454-459.
产品手册
关联产品
-
STAT5b inhibitor 7
STAT5b抑制剂7(Capstafin前药)是Capstafin的新戊酰氧基甲酯前药。
-
BTA-9881
BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
-
Totrombopag
Totrombopag (SB559448) is a candidate compound for action on RSV polymerase.
021-51111890
购物车()
sales@molnova.cn

